Ambiq Micro, Inc. (“Ambiq”) (NYSE: AMBQ), a technology leader in ultra-low-power semiconductor solutions for edge AI, today announced financial results for the third quarter of 2025.
Ambiq Micro, Inc. (NYSE: AMBQ), a technology leader in ultra-low-power semiconductor solutions for edge AI, today announced that it will report its third quarter 2025 financial results on Thursday, November 6, 2025 after market close. The Company will host a conference call at 4:00 p.m. Central Time (5:00 p.m. Eastern Time) to discuss the results.
Jim Cramer recommends caution with Ambiq Micro (AMBQ) and suggests Broadcom (AVGO). He dislikes Albertsons (ACI) and advises selling some Dillard's (DDS).
Gainers U-BX Technology (NASDAQ: UBXG) shares rose 10.5% to $2.0 during Thursday's pre-market session. The market value of their outstanding shares is at $37.6 million.
Ambiq Micro, Inc. (“Ambiq”) (NYSE: AMBQ), a technology leader in ultra-low-power semiconductor solutions for edge AI, today announced financial results for the second quarter of 2025.
Ambiq Micro, Inc. (Ambiq), a technology leader in ultra-low-power semiconductor solutions for edge AI, today announced the expansion of the Apollo5 Family with the Apollo510B wireless System-on-Chip (SoC). Integrating a dedicated 48MHz network processor and Bluetooth® Low Energy 5.4 radio, the Apollo510B will enable robust wireless connectivity for power-constrained edge AI applications.
Ambiq Micro, Inc. (NYSE: AMBQ), a technology leader in ultra-low-power semiconductor solutions for edge AI, will release its second quarter 2025 financial results on Thursday, September 4, 2025 after market close. Fumihide Esaka, Chief Executive Officer, and Jeff Winzeler, Chief Financial Officer, will host a conference call at 3:30 p.m. Central Time (4:30 p.m. Eastern Time) to discuss its results.
AUSTIN, Texas, July 31, 2025 (GLOBE NEWSWIRE) -- Ambiq Micro, Inc. (“Ambiq”), a technology leader in ultra-low-power semiconductor solutions for edge AI, today announced the closing of its upsized initial public offering of 4,600,000 shares of its common stock, including the full exercise of the underwriters’ option to purchase 600,000 additional shares, at a public offering price of $24.00 per share. The gross proceeds to Ambiq from the offering, before deducting underwriting discounts and commissions and other offering expenses payable by Ambiq, were $110.4 million. The shares began trading on the New York Stock Exchange under the ticker symbol “AMBQ” on July 30, 2025.
